相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor vascular infarction: prospects and challenges
Rana Jahanban-Esfahlan et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2017)
Breast tumor stroma: A driving force in the development of resistance to therapies
Maryam Majidinia et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
The crosstalk between Wnt/β-catenin signaling pathway with DNA damage response and oxidative stress: Implications in cancer therapy
Ansar Karimaian et al.
DNA REPAIR (2017)
Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy
Shi Gao et al.
BIOMATERIALS (2017)
Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin
Zaheer Ahmad et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2016)
Carbon-Dot-Decorated Carbon Nitride Nanoparticles for Enhanced Photodynamic Therapy against Hypoxic Tumor via Water Splitting
Di-Wei Zheng et al.
ACS NANO (2016)
Modulation of Hypoxia in Solid Tumor Microenvironment with MnO2 Nanoparticles to Enhance Photodynamic Therapy
Wenwen Zhu et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Intelligent Albumin-MnO2 Nanoparticles as pH-/H2O2-Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy
Qian Chen et al.
ADVANCED MATERIALS (2016)
Perfluorocarbon-Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer
Guosheng Song et al.
ADVANCED MATERIALS (2016)
Integrin αvβ3-Targeted C-Dot Nanocomposites as Multifunctional Agents for Cell Targeting and Photoacoustic Imaging of Superficial Malignant Tumors
Zhe Liu et al.
ANALYTICAL CHEMISTRY (2016)
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug-Resistance: Opportunity or Challenge
Bahman Yousefi et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2016)
Hypoxia Responsive, Tumor Penetrating Lipid Nanoparticles for Delivery of Chemotherapeutics to Pancreatic Cancer Cell Spheroids
Prajakta Kulkarni et al.
BIOCONJUGATE CHEMISTRY (2016)
Hypoxia-Responsive Polymersomes for Drug Delivery to Hypoxic Pancreatic Cancer Cells
Prajakta Kulkarni et al.
BIOMACROMOLECULES (2016)
Hybrid graphene/Au activatable theranostic agent for multimodalities imaging guided enhanced photothermal therapy
Shi Gao et al.
BIOMATERIALS (2016)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Hypoxia-responsive nanocarriers for cancer imaging and therapy: recent approaches and future perspectives
Thavasyappan Thambi et al.
CHEMICAL COMMUNICATIONS (2016)
Redox responsive liposomal nanohybrid cerasomes for intracellular drug delivery
Gaoxin Zhou et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
DNA damage response regulation by microRNAs as a therapeutic target in cancer
Maryam Majidinia et al.
DNA REPAIR (2016)
Long non-coding RNAs in cancer drug resistance development
Maryam Majidinia et al.
DNA REPAIR (2016)
Liposome encapsulated perfluorohexane enhances radiotherapy in mice without additional oxygen supply
Linfeng Xu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors
Yutaka Ikeda et al.
MOLECULAR PHARMACEUTICS (2016)
Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy
Cheng-Hung Luo et al.
NANO LETTERS (2016)
Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies
Xuejiao Song et al.
NANO LETTERS (2016)
Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Ouajdi Felfoul et al.
NATURE NANOTECHNOLOGY (2016)
Tf-PEG-PLL-PLGA nanoparticles enhanced chemosensitivity for hypoxia-responsive tumor cells
Ping Liu et al.
ONCOTARGETS AND THERAPY (2016)
Targeting hypoxic response for cancer therapy
Elisa Paolicchi et al.
ONCOTARGET (2016)
Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy
Wei Li et al.
SCIENTIFIC REPORTS (2016)
Self-Monitoring Artificial Red Cells with Sufficient Oxygen Supply for Enhanced Photodynamic Therapy
Zhenyu Luo et al.
SCIENTIFIC REPORTS (2016)
Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer
Tingjie Yin et al.
BIOMATERIALS (2015)
Tumortropic monocyte-mediated delivery of echogenic polymer bubbles and therapeutic vesicles for chemotherapy of tumor hypoxia
Wen-Chia Huang et al.
BIOMATERIALS (2015)
Nanotechnological carriers for cancer chemotherapy: The state of the art
Marilene Estanqueiro et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Hypoxia Activated Prodrugs: Factors Influencing Design and Development
Dinghua Liang et al.
CURRENT MEDICINAL CHEMISTRY (2015)
Aptamers in Targeted Nanotherapy
Anila Mathew et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Edgar Perez-Herrero et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Biological evaluation of redox-sensitive micelles based on hyaluronic acid-deoxycholic acid conjugates for tumor-specific delivery of paclitaxel
Jing Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia
Wen-Chia Huang et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
H2O2-Activatable and O2-Evolving Nanoparticles for Highly Efficient and Selective Photodynamic Therapy against Hypoxic Tumor Cells
Huachao Chen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Hypoxia-inducible factor 1 and breast cancer metastasis
Zhao-ji Liu et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting
Tingjie Yin et al.
MOLECULAR PHARMACEUTICS (2015)
Aptamers and Their Applications in Nanomedicine
Hongguang Sun et al.
SMALL (2015)
Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapy
Yuhao Cheng et al.
NATURE COMMUNICATIONS (2015)
Self-assembling nanoparticles encapsulating zoledronic acid revert multidrug resistance in cancer cells
Joanna Kopecka et al.
ONCOTARGET (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
Oral and IV Dosages of Doxorubicin-Methotrexate loaded-Nanoparticles Inhibit Progression of Oral Cancer by Down-Regulation of Matrix Methaloproteinase 2 Expression in Vivo
Mehran Mesgari Abbasi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Nanodrug Delivery Systems: A Promising Technology for Detection, Diagnosis, and Treatment of Cancer
Anish Babu et al.
AAPS PHARMSCITECH (2014)
Multifunctional Albumin-MnO2 Nanoparticles Modulate Solid Tumor Microenvironment by Attenuating Hypoxia, Acidosis, Vascular Endothelial Growth Factor and Enhance Radiation Response
Preethy Prasad et al.
ACS NANO (2014)
Novel DOX-MTX Nanoparticles Improve Oral SCC Clinical Outcome by Down Regulation of Lymph Dissemination Factor VEGF-C Expression in vivo: Oral and IV Modalities
Mehran Mesgari Abbasi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
DOX-MTX-NPs Augment p53 mRNA Expression in OSCC Model in Rat: Effects of IV and Oral Routes
Mehran Mesgari Abbasi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
New formulated DOX-MTX- loaded Nanoparticles Down-regulate HER2 Gene Expression and Improve the Clinical Outcome in OSCCs Model in Rat: the Effect of IV and Oral Modalities
Mehran Mesgari Abbasi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Macrophages associated with tumors as potential targets and therapeutic intermediates
Serguei Vinogradov et al.
NANOMEDICINE (2014)
A graphene quantum dot photodynamic therapy agent with high singlet oxygen generation
Jiechao Ge et al.
NATURE COMMUNICATIONS (2014)
Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
Christopher P. Guise et al.
CHINESE JOURNAL OF CANCER (2014)
Gold nanoparticles and their alternatives for radiation therapy enhancement
Daniel R. Cooper et al.
FRONTIERS IN CHEMISTRY (2014)
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
Norma Masson et al.
CANCER & METABOLISM (2014)
CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A
Cindy Cazares-Koerner et al.
ACS CHEMICAL BIOLOGY (2013)
HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression
Beatrice Philip et al.
CARCINOGENESIS (2013)
Strategies for optimizing the response of cancer and normal tissues to radiation
Everett J. Moding et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Photosensitizer-conjugated polymeric nanoparticles for redox-responsive fluorescence imaging and photodynamic therapy
Hyunjin Kim et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling
Annika Foehrenbacher et al.
FRONTIERS IN ONCOLOGY (2013)
Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel
Jing Li et al.
BIOMATERIALS (2012)
Bacterial vectors for imaging and cancer gene therapy: a review
M. Cronin et al.
CANCER GENE THERAPY (2012)
Antibody-Conjugated Nanoparticles for Therapeutic Applications
M. M. Cardoso et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
Vikash P. Chauhan et al.
NATURE NANOTECHNOLOGY (2012)
Imaging hypoxia to improve radiotherapy outcome
Michael R. Horsman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Hypoxia-regulated target genes implicated in tumor metastasis
Ya-Ping Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Targeting hypoxic tumour cells to overcome metastasis
Kevin L. Bennewith et al.
BMC CANCER (2011)
Mechanisms of Resistance to Photodynamic Therapy
A. Casas et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Peter Carmeliet et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
HIF-1: upstream and downstream of cancer metabolism
Gregg L. Semenza
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma
Guichun Huang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Bacteria in cancer therapy: a novel experimental strategy
S. Patyar et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Yuri Kim et al.
CURRENT MOLECULAR MEDICINE (2009)
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Sara Rockwell et al.
CURRENT MOLECULAR MEDICINE (2009)
Aptamer Nano-flares for Molecular Detection in Living Cells
Dan Zheng et al.
NANO LETTERS (2009)
Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression
Pedro C. Lara et al.
RADIATION ONCOLOGY (2009)
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
Gregg L. Semenza
SEMINARS IN CANCER BIOLOGY (2009)
MECHANISMS OF CHEMOTHERAPEUTIC DRUG RESISTANCE IN CANCER THERAPY-A QUICK REVIEW
Fu-Shing Liu
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2009)
Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression
Jean-Philippe Cosse et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2008)
Bacterial targeted tumour therapy-dawn of a new era
Ming Q. Wei et al.
CANCER LETTERS (2008)
Hypoxia-inducible factor 1 and cancer pathogenesis
Gregg L. Semenza
IUBMB LIFE (2008)
Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moieties
S. Kumar et al.
NATURE PROTOCOLS (2008)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
Tumor hypoxia: A target for selective cancer therapy
S Kizaka-Kondoh et al.
CANCER SCIENCE (2003)
Use of bacteria as anticancer agents
KK Jain
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia induced radiation resistance rather than hypoxia-induced metastasis
EK Rofstad et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
